Putnam Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $3.26M | Buy |
+17,055
| New | +$3.26M | ﹤0.01% | 608 |
|
|
2022
Q4 | – | Sell |
-72,194
| Closed | -$14.5M | – | 1136 |
|
|
2022
Q3 | $14.5M | Buy |
72,194
+43,294
| +150% | +$8.67M | 0.03% | 233 |
|
|
2022
Q2 | $4.22M | Buy |
+28,900
| New | +$4.22M | 0.01% | 482 |
|
|
2021
Q2 | – | Sell |
-82,300
| Closed | -$11.6M | – | 780 |
|
|
2021
Q1 | $11.6M | Buy |
+82,300
| New | +$11.6M | 0.02% | 350 |
|
|
2020
Q3 | – | Sell |
-27,541
| Closed | -$4.08M | – | 826 |
|
|
2020
Q2 | $4.08M | Buy |
+27,541
| New | +$4.08M | 0.01% | 509 |
|
|
2019
Q3 | – | Sell |
-80,500
| Closed | -$5.84M | – | 888 |
|
|
2019
Q2 | $5.84M | Buy |
+80,500
| New | +$5.84M | 0.01% | 479 |
|
|
2018
Q3 | – | Sell |
-12,660
| Closed | -$1.25M | – | 1067 |
|
|
2018
Q2 | $1.25M | Buy |
+12,660
| New | +$1.25M | ﹤0.01% | 822 |
|
|
2017
Q4 | – | Sell |
-134,572
| Closed | -$15.8M | – | 1079 |
|
|
2017
Q3 | $15.8M | Buy |
+134,572
| New | +$15.8M | 0.04% | 299 |
|